B |
2020-02-03 16:55:00.0 |
PUMA BIOTECHNOLOGY |
PBYI |
INTEGRATED CORE STRATEGIES |
5.0% |
view |
B |
2019-02-11 11:47:53.0 |
PUMA BIOTECHNOLOGY |
PBYI |
JANUS HENDERSON GROUP PLC |
7.0% |
view |
S |
2018-10-10 12:46:01.0 |
PUMA BIOTECHNOLOGY |
PBYI |
PRICE T ROWE ASSOCIATES INC |
5.2% |
view |
S |
2018-02-12 09:38:21.0 |
PUMA BIOTECHNOLOGY |
PBYI |
WELLINGTON MANAGEMENT GROUP LLP |
0.06% |
view |
B |
2018-02-01 09:24:09.0 |
PUMA BIOTECHNOLOGY |
PBYI |
JANUS HENDERSON GROUP PLC |
11.6% |
view |
B |
2018-01-10 15:38:12.0 |
PUMA BIOTECHNOLOGY |
PBYI |
JANUS HENDERSON GROUP PLC |
11.6% |
view |
S |
2017-12-11 14:37:45.0 |
PUMA BIOTECHNOLOGY |
PBYI |
ADAGE CAPITAL PARTNERS GP |
6.72% |
view |
S |
2016-02-10 11:03:55.0 |
PUMA BIOTECHNOLOGY |
PBYI |
PRICE T ROWE ASSOCIATES INC |
5.3% |
view |
B |
2014-02-12 14:32:18.0 |
PUMA BIOTECHNOLOGY |
PBYI |
ADAGE CAPITAL PARTNERS GP LLC |
19.82% |
view |
S |
2013-02-12 21:00:19.0 |
PUMA BIOTECHNOLOGY |
PBYI |
ADAGE CAPITAL PARTNERS GP LLC |
20.0% |
view |
B |
2011-10-04 15:59:35.0 |
INNOVATIVE ACQUISITIONS CORP |
n/a |
MUNJAL KAPIL |
33.33% |
view |